Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

Carsten Weishaupt, Anke Strölin, Birgit Kahle, Alexander Kreuter, Stefan W Schneider, Joachim Gerss, Maria Eveslage, Attyla Drabik, Tobias Goerge

Fingerprint

Dive into the research topics of 'Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial'. Together they form a unique fingerprint.

Medicine & Life Sciences